Jason Wickens, MD
Ophthalmology · Las Vegas, NVNPI 1003860313
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,236 of the $1,737 with a category attached, or 71.2%. 17 manufacturers reported payments, led by Alcon at 24.9% of the total. Reporting peaked in 2019 at $467 and has fallen 70.1% since, to $140 in 2025. That places this record below the midpoint for ophthalmology clinicians in NV, where the typical reported total is $1,540.
Across 44 payments — averaging $39.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$432
- Genentech USA, Inc.$297
- Apellis Pharmaceuticals, Inc.$205
- Astellas Pharma US Inc$138
- Regeneron$121
- NEW World Medical,inc.$86
- plus $459 from 11 others
Across 6 payments — averaging $2620.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$16K
What the payments were for
- Food & beverage$1,23671%
- Education$885%
- Gifts$39423%
- Entertainment$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 3 | $432 |
| Genentech USA, Inc. | 11 | $297 |
| Apellis Pharmaceuticals, Inc. | 5 | $205 |
| Astellas Pharma US Inc | 1 | $138 |
| Regeneron | 2 | $121 |
| NEW World Medical,inc. | 1 | $86 |
| Alimera Sciences, Inc. | 1 | $76 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| AbbVie(2 entities) | 4 | $71 |
| Bausch & Lomb Americas Inc. | 3 | $54 |
| Abbott | 3 | $43 |
| Oculus Surgical Inc. | 1 | $34 |
| Amgen | 1 | $27 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $25 |
| Biogen | 1 | $20 |
| Optos, Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$394
- VABYSMO$150
- Izervay$138
- EYLEA$103
How this compares
$1,737 in reported general payments places this provider in the 50th percentile of 121 ophthalmology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 245 | $9,346 |
| Ketorolac Tromethamine | 133 | $4,422 |
| ValacyclovirValacyclovir Hcl | 35 | $3,405 |
| MoxifloxacinMoxifloxacin Hcl | 124 | $3,370 |
| Bromfenac Sodium | 21 | $2,747 |
| Brimonidine Tartrate | 29 | $1,724 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 71 | $1,009 |
| Latanoprost | 23 | $313 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Las Vegas
- Eva LiangLas Vegas$496K
- Steven LeibowitzLas Vegas$147K
- Wonchon LinLas Vegas$43K
- Ravindranath ReddyLas Vegas$30K
- Emily SchorrLas Vegas$17K
- Frank LeeLas Vegas$12K
- Tigran KostanyanLas Vegas$11K
- Tushina ReddyLas Vegas$11K
- Kent WellishLas Vegas$10K
- Eissa HannaLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.